Henry Schein acquires R. Weinstein, Inc., a medical distributor serving Hawaii’s health care sector; Henry Schein Medical strengthens SolutionsHub with DoctorLogic
Henry Schein, Inc. announced that it has acquired R. Weinstein, Inc. (R. Weinstein), a provider of vaccines, medical-surgical products, and equipment to Hawaii-based health care facilities and practitioners. Headquartered in Honolulu, R. Weinstein was established in 1984 and reported sales of approximately $11 million in 2024. The financial terms of the transaction were not disclosed.
The acquisition of R. Weinstein strengthens Henry Schein’s presence across the Hawaiian Islands while offering R. Weinstein’s customers access to the Company’s expanded distribution network and comprehensive portfolio of products, services, technology, and supply chain solutions.
Also, the company announced that Henry Schein Medical will expand its SolutionsHub with the addition of DoctorLogic, a digital marketing service and website platform for health care practices. The DoctorLogic platform’s suite of features includes website design, search engine optimization (SEO), reputation management, and AI tools for optimizing marketing performance.
The DoctorLogic platform’s suite of features includes website design, search engine optimization (SEO), reputation management, and AI tools for optimizing marketing performance.
“We are excited to be a part of Henry Schein’s SolutionsHub,” said Stuart Lloyd, Head of Strategy, DoctorLogic. “DoctorLogic’s platform is designed to help health care providers attract and retain patients by optimizing a practice’s online presence, delivering data-driven marketing insights, and providing content-rich, patient-friendly websites. Together, we can help practices increase their online presence, connect with more patients, and offer an enhanced patient experience.”
This collaboration reinforces Henry Schein Medical’s commitment to providing innovative solutions that support practice growth and enhance patient experience.
“Our customers are at the heart of everything we do. We strive to anticipate their needs and find new ways to help practices succeed,” said Emily Jimenez, Director of Solution Sales, Henry Schein Medical. “Adding DoctorLogic to our SolutionsHub portfolio enhances the range of services we offer to help health care professionals attract and retain patients, and further demonstrates Henry Schein’s commitment to supporting the growth of our customers. Health care professionals will benefit from access to DoctorLogic’s suite of digital marketing and practice growth solutions through the Henry Schein SolutionsHub, a one-stop destination for innovative practice management resources.
New BD fingertip blood collection device has equivalent testing accuracy of higher-volume draws from vein
BD announced the results of new studies demonstrating that blood tests commonly used in wellness checks and chronic disease management are just as accurate when using several drops of blood collected from a finger prick as when the sample is taken from a vein. The novel BD® MiniDraw™ Capillary Blood Collection technology used in the studies, which is a key enabler in Babson’s BetterWay™ blood testing service, provides a patient-friendly alternative to venipuncture and expands access to more convenient locations.
Three studies evaluated accuracy and within-tube stability over time for fingertip capillary blood samples collected, processed, transported and stored using the BD® MiniDraw™ Capillary Blood Collection System along with BD® MiniDraw™ SST™ Capillary Blood Collection Tube versus blood samples obtained via venous and conventional capillary collection methods by a licensed phlebotomist. A peer-reviewed article published in the Journal of Applied Laboratory Medicine showed that capillary collection using the BD® MiniDraw™ Capillary Blood Collection System was clinically equivalent to conventional collection methods for selected general chemistry analytes used frequently in wellness checks and for diagnosing and monitoring some chronic conditions, including kidney, liver and cardiac diseases.